Brief: IGC Acquires Exclusive Rights For A Potential Alzheimer's Drug Development Candidate

IGC Pharma

21/06/2022 05:18

June 21 (Reuters) - India Globalization Capital Inc  IGC.A :
    * IGC ACQUIRES EXCLUSIVE RIGHTS FOR A POTENTIAL ALZHEIMER’S
DRUG
DEVELOPMENT CANDIDATE
    * IGC - ACQUIRED EXCLUSIVE GLOBAL RIGHTS TO THE MOLECULE AND
PLANS
TO DEVELOP THIS NMI LEAD CANDIDATE FURTHER
    * IGC - CURRENTLY IN HUMAN TRIALS WITH IGC-AD1 THAT TARGETS
NEUROPSYCHIATRIC SYMPTOMS ASSOCIATED WITH DEMENTIA IN
ALZHEIMER’S

Source text for Eikon:  ID:nBw7V9L7na 
Further company coverage:  IGC.A 

 ((Reuters.Briefs@thomsonreuters.com;))